Current Vascular Pharmacology

Editor-in-Chief:

Dimitri P. Mikhailidis  
Academic Head, Department of Clinical Biochemistry
Royal Free Hospital Campus
University College London Medical School
University College London (UCL)
Pond Street, London, NW3 2QG
UK

Back

Become EABM
Become Reviewer

Editorial [PCI and Stable Coronary Heart Disease - COURAGE to Change Our Minds?] promotion: free to download

Volume:5   Issue: 3
Pp: 173-174
Anna I. Kakafika, Dimitri P. Mikhailidis, Anthony S. Wierzbicki, Asterios Karagiannis and Vasilios G. Athyros
DOI: 10.2174/157016107781024145

Cannabinoids and Cardiovascular Disease: The Outlook for Clinical Treatments

Volume:5   Issue: 3
Pp: 175-184
John C. Ashton and Paul F. Smith
DOI: 10.2174/157016107781024109

Novel Anti-Arrhythmic Drugs for Atrial Fibrillation Management

Volume:5   Issue: 3
Pp: 185-194
Joachim R. Ehrlich, Stanley Nattel and Stefan H. Hohnloser
DOI: 10.2174/157016107781024073

Angiogenic Growth Factors in the Treatment of Peripheral Arterial Disease

Volume:5   Issue: 3
Pp: 195-209
Dimitrios Mikroulis, Nikolaos Papanas, Efstratios Maltezos and Georgios Bougioukas
DOI: 10.2174/157016107781024136

New Pharmacologic Approaches to Prevent Thromboembolism in Patients with Atrial Fibrillation

Volume:5   Issue: 3
Pp: 211-219
Matthias Hammwohner, Alessandra D'Alessandro, Oliver Wolfram and Andreas Goette
DOI: 10.2174/157016107781024118

Beneficial Effects of Statins on Endothelial Dysfunction and Vascular Stiffness

Volume:5   Issue: 3
Pp: 227-237
Polychronis Dilaveris, Georgios Giannopoulos, Maria Riga, Andreas Synetos and Christodoulos Stefanadis
DOI: 10.2174/157016107781024091

The Endothelin Axis: A Novel Target for Pharmacotherapy of Female Malignancies

Volume:5   Issue: 3
Pp: 239-248
Martin Smollich and Pia Wulfing
DOI: 10.2174/157016107781024082